Atopic dermatitis: a review of topical treatment options

References

• Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ 2006;332:584-8
   PubMed Web of Science ®Google Scholar
• Wüthrich B. Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999;83:464-70
   PubMed Web of Science ®Google Scholar
• Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999;103:125-38
   PubMed Web of Science ®Google Scholar
• Uehara M, Kimura C. Descendant family history of atopic dermatitis. Acta Derm Venereol 1993;73:62-3
   PubMed Web of Science ®Google Scholar
• Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118-27
   PubMed Web of Science ®Google Scholar
• Bender BG, Ballard R, Canono B, et al. Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol 2008;58:415-20
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-30
   PubMed Web of Science ®Google Scholar
• Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Derm Venereol (Stockh) 1980;92:44-7
   Google Scholar
• Eichenfield LF, Hanifin JM, Luger TA, et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003;49:1088-95
   PubMedGoogle Scholar
• Lodén M. Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream. Contact Dermatitis 1997;36:256-60
   PubMed Web of Science ®Google Scholar
• Loden M. The skin barrier and use of moisturizers in atopic dermatitis. Clin Dermatol 2003;21:145-57
   PubMed Web of Science ®Google Scholar
• Lucky AW, Leach AD, Laskarzewski P, et al. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997;14:321-4
   PubMed Web of Science ®Google Scholar
• Szczepanowska J, Reich A, Szepietowski JC. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr Allergy Immunol 2008;19:614-18
   PubMed Web of Science ®Google Scholar
• Di Nardo A, Wertz P, Giannetti A, et al. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998;78:27-30
   PubMed Web of Science ®Google Scholar
• Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999;140:264-7
   PubMed Web of Science ®Google Scholar
• Loden M, Andersson AC, Andersson C, et al. Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res Technol 2001;7:209-13
   PubMed Web of Science ®Google Scholar
• Soma Y, Kashima M, Imaizumi A, et al. Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol 2005;44:197-202
   PubMed Web of Science ®Google Scholar
• Loden M, Andersson AC, Anderson C, et al. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol 2002;82:45-7
   PubMed Web of Science ®Google Scholar
• Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002;47:198-208
   PubMed Web of Science ®Google Scholar
• Loden M, Barany E. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. Acta Derm Venereol 2000;80:412-15
   PubMed Web of Science ®Google Scholar
• Simpson E, Brown P, Berry T, et al. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. International Symposium of Atopic Dermatitis, Kyoto, Japan, 2008
   Google Scholar
• Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association ‘Administrative Regulations for Evidence-Based Clinical Practice Guidelines’. J Am Acad Dermatol 2004;50:391-404
   PubMed Web of Science ®Google Scholar
• Akers WA. Risks of unoccluded topical steroids in clinical trials. Arch Dermatol 1980;116:786-8
   PubMed Web of Science ®Google Scholar
• Patel L, Clayton PE, Addison GM, et al. Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol 1995;132:950-5
   PubMed Web of Science ®Google Scholar
• Callen J, Chamlin S, Eichenfield LF, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol 2007;156:203-21
   PubMed Web of Science ®Google Scholar
• Berth-Jones J, Damstra RJ, Golsch S, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003;326:1367
   PubMed Web of Science ®Google Scholar
• Munzenberger PJ, Montejo JM. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Pharmacotherapy 2007;27:1020-8
   PubMed Web of Science ®Google Scholar
• Kang S, Lucky AW, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001;44:S58-64
   PubMed Web of Science ®Google Scholar
• Protopic Prescribing Information. Astellas Pharma US, Inc. 2006. Available at: http://www.astellas.us/docs/protopic.pdf [Last accessed 18 December 2008]
   Google Scholar
• Elidel Prescribing Information. Novartis Pharmaceuticals Corp., 2006. Available at: http://www.pharma.us.novartis.com/product/pi/pdf/elidel.pdf [Last accessed 18 December]
   Google Scholar
• Hanifin JM, Paller AS, Eichenfield L, et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol 2005;53:S186-94
   PubMed Web of Science ®Google Scholar
• Paller AS, Lebwohl M, Fleischer AB Jr, et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 2005;52:810-22
   PubMed Web of Science ®Google Scholar
• Breneman D, Fleischer AB Jr, Abramovits W, et al. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. J Am Acad Dermatol 2008;58:990-9
   PubMed Web of Science ®Google Scholar
• Gollnick H, Kaufmann R, Stough D, et al. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. Br J Dermatol 2008;158:1083-93
   PubMed Web of Science ®Google Scholar
• Draelos ZD. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas. Curr Med Res Opin 2008;24:985-94
   PubMed Web of Science ®Google Scholar
• Abramovits W, Boguniewicz M. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol 2006;5:236-44
   PubMedGoogle Scholar
• Eberlein B, Eicke C, Reinhardt HW, et al. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 2008;22:73-82
   PubMed Web of Science ®Google Scholar
• Lambert DM, Vandevoorde S, Jonsson KO, et al. The palmitoylethanolamide family: a new class of anti-inflammatory agents?. Curr Med Chem 2002;9:663-74
   PubMed Web of Science ®Google Scholar
• Madaan A. Epiceram for the treatment of atopic dermatitis. Drugs Today (Barc) 2008;44:751-5
   PubMed Web of Science ®Google Scholar
• Patrizi A, Capitanio B, Neri I, et al. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR(TM)) in the management of atopic dermatitis in paediatric patients. Pediatr Allergy Immunol 2008;19:619-25
   PubMed Web of Science ®Google Scholar
• Abramovits W, Perlmutter A. MimyX cream. Skinmed 2006;5:29-30
   PubMedGoogle Scholar
• Simpson E, Tofte S, Hanifin J, et al. EpiCeram for the Treatment of Mild-to-Moderate Atopic Dermatitis – A Pilot Study International Investigative Dermatology Meeting, Kyoto, Japan, 2008
   Google Scholar
• Ohya Y, Williams H, Steptoe A, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 2001;117:852-7
   PubMed Web of Science ®Google Scholar
• Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol 2003;28:549-53
   PubMed Web of Science ®Google Scholar
• Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000;142:931-6
   PubMed Web of Science ®Google Scholar
• Cork MJ, Britton J, Butler L, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149:582-9
   PubMed Web of Science ®Google Scholar
• Feldman SR, Camacho FT, Krejci-Manwaring J, et al Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 2007;57:81-3
   PubMed Web of Science ®Google Scholar